Neovacs SA's total assets for Q4 2024 were €22.07M, a decrease of -49.75% from the previous quarter. DE:0LW total liabilities were €4.01M for the fiscal quarter, a -84.15% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.